Location History:
- Changping, CN (2019)
- Taicang, CN (2020)
- Quebec, CA (2021)
Company Filing History:
Years Active: 2019-2021
Title: Innovations and Contributions of Jie Cai
Introduction
Jie Cai is a notable inventor based in Taicang, China. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of three patents to his name, Jie Cai is recognized for his work in developing methods that enhance the efficacy of multi-kinase inhibitors in treating cancer.
Latest Patents
Jie Cai's latest patents include groundbreaking research on gene expression signatures that predict a subject's response to multi-kinase inhibitors. One of his patents discloses methods for predicting the efficacy of these inhibitors for treating cancer in patients. It also includes techniques for distinguishing between responders and non-responders to the treatment. Another significant patent involves the HNF4G-RSPO2 fusion gene, providing methods for detecting this fusion gene in nucleic acid-containing samples. This patent also includes a primer set, a probe set, and a kit for detecting the fusion gene, along with animal models for human diseases associated with the fusion gene.
Career Highlights
Jie Cai is currently employed at Crown Bioscience, Inc., where he continues to advance his research in cancer treatment. His work has been instrumental in developing innovative solutions that address critical challenges in oncology.
Collaborations
Some of Jie Cai's notable coworkers include Henry Qixiang Li and Jie Yang, who collaborate with him on various research projects aimed at improving cancer therapies.
Conclusion
Jie Cai's contributions to the field of cancer treatment through his innovative patents highlight his dedication to advancing medical science. His work not only enhances the understanding of cancer treatment but also provides valuable tools for improving patient outcomes.